» Articles » PMID: 30564232

Proteomics, Bioinformatics and Structure-Function Antigen Mining For Gonorrhea Vaccines

Overview
Journal Front Immunol
Date 2018 Dec 20
PMID 30564232
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Expanding efforts to develop preventive gonorrhea vaccines is critical because of the serious health consequences combined with the prevalence and the dire possibility of untreatable gonorrhea. Reverse vaccinology, which includes genome and proteome mining, has proven successful in the discovery of vaccine candidates against many pathogenic bacteria. Here, we describe proteomic applications including comprehensive, quantitative proteomic platforms and immunoproteomics coupled with broad-ranging bioinformatics that have been applied for antigen mining to develop gonorrhea vaccine(s). We further focus on outlining the vaccine candidate decision tree, describe the structure-function of novel proteome-derived antigens as well as ways to gain insights into their roles in the cell envelope, and underscore new lessons learned about the fascinating biology of .

Citing Articles

Profiling IgG and IgA antibody responses during vaccination and infection in a high-risk gonorrhoea population.

Stejskal L, Thistlethwaite A, Ramirez-Bencomo F, Rashmi S, Harrison O, Feavers I Nat Commun. 2024; 15(1):6712.

PMID: 39112489 PMC: 11306574. DOI: 10.1038/s41467-024-51053-x.


How Proteomics Can Inform Vaccine Design for Sexually Transmitted Infections.

Goodyear M, Cameron C Sex Transm Dis. 2024; 51(10):e36-e39.

PMID: 38860670 PMC: 11392604. DOI: 10.1097/OLQ.0000000000001986.


Addressing Sexually Transmitted Infections Due to in the Present and Future.

Colon Perez J, Villarino Fernandez R, Dominguez Lago A, Trevino Castellano M, Perez Del Molino Bernal M, Sanchez Poza S Microorganisms. 2024; 12(5).

PMID: 38792714 PMC: 11124187. DOI: 10.3390/microorganisms12050884.


Characterization of protective immune responses against induced by intranasal immunization with adhesion and penetration protein.

Xia L, Lu Q, Wang X, Jia C, Zhao Y, Wang G Heliyon. 2024; 10(3):e25733.

PMID: 38352762 PMC: 10862674. DOI: 10.1016/j.heliyon.2024.e25733.


vaccines: a contemporary overview.

Williams E, Seib K, Fairley C, Pollock G, Hocking J, McCarthy J Clin Microbiol Rev. 2024; 37(1):e0009423.

PMID: 38226640 PMC: 10938898. DOI: 10.1128/cmr.00094-23.


References
1.
Zielke R, Le Van A, Baarda B, Herrera M, Acosta C, Jerse A . SliC is a surface-displayed lipoprotein that is required for the anti-lysozyme strategy during Neisseria gonorrhoeae infection. PLoS Pathog. 2018; 14(7):e1007081. PMC: 6033465. DOI: 10.1371/journal.ppat.1007081. View

2.
Ragland S, Humbert M, Christodoulides M, Criss A . Neisseria gonorrhoeae employs two protein inhibitors to evade killing by human lysozyme. PLoS Pathog. 2018; 14(7):e1007080. PMC: 6033460. DOI: 10.1371/journal.ppat.1007080. View

3.
Hung M, Heckels J, Christodoulides M . The adhesin complex protein (ACP) of Neisseria meningitidis is a new adhesin with vaccine potential. mBio. 2013; 4(2). PMC: 3585444. DOI: 10.1128/mBio.00041-13. View

4.
Soria-Guerra R, Nieto-Gomez R, Govea-Alonso D, Rosales-Mendoza S . An overview of bioinformatics tools for epitope prediction: implications on vaccine development. J Biomed Inform. 2014; 53:405-14. DOI: 10.1016/j.jbi.2014.11.003. View

5.
Basta N, Christensen H . 4CMenB vaccine effectiveness: reasons for optimism. Lancet. 2017; 388(10061):2719-2721. PMC: 5424821. DOI: 10.1016/S0140-6736(16)32061-X. View